A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from USC suggests that semaglutide—the drug marketed as Ozempic for diabetes and Wegovy for obesity—may also help reduce alcohol consumption.

Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use disorder, a new study suggests.

A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder. How the meds work in the brain.

A breakthrough study reveals that semaglutide, found in Ozempic and Wegovy, could help reduce alcohol cravings and heavy drinking episodes in adults.

S emaglutide, the drug sold as Ozempic to treat type 2 diabetes and Wegovy for weight loss, reduced alcohol cravings and consumption in a small trial involving peop

Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.